Deborah J Burt

Author PubWeight™ 7.89^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	Modulation of lymphocyte regulation for cancer therapy: a phase II trial of tremelimumab in advanced gastric and esophageal adenocarcinoma.	Clin Cancer Res	2010	1.14
2	Tremelimumab (anti-CTLA4) mediates immune responses mainly by direct activation of T effector cells rather than by affecting T regulatory cells.	Clin Immunol	2010	0.99
3	Expanded subpopulation of FoxP3+ T regulatory cells in renal cell carcinoma co-express Helios, indicating they could be derived from natural but not induced Tregs.	Clin Immunol	2011	0.95
4	An MVA-based vaccine targeting the oncofetal antigen 5T4 in patients undergoing surgical resection of colorectal cancer liver metastases.	J Immunother	2008	0.89
5	Adoptive transfer of T(reg) depleted autologous T cells in advanced renal cell carcinoma.	Cancer Immunol Immunother	2007	0.85
6	Immune evasion mechanisms in colorectal cancer liver metastasis patients vaccinated with TroVax (MVA-5T4).	Cancer Immunol Immunother	2009	0.85
7	CD8 T-cell recognition of human 5T4 oncofetal antigen.	Int J Cancer	2006	0.83
8	CD4+ T-cell recognition of human 5T4 oncofoetal antigen: implications for initial depletion of CD25+ T cells.	Cancer Immunol Immunother	2007	0.79
9	Circulating regulatory T cells in endometrial cancer: a role for age and menopausal status.	Immunol Invest	2010	0.77